B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma

Yuqian Wang,1,* Zhilong Zhao,2,* Chenlu Liu,3 Miao Hao,1 Chenfei Kong,1 Xiaoming Zhao,1 Yiyao Gao,1 Yucheng Zhang,1 Wanxing Cui,4 Congxiao Zhang,2 Jinlan Jiang1 1Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, 130031, People’s Republic of China; 2...

Full description

Bibliographic Details
Main Authors: Wang Y, Zhao Z, Liu C, Hao M, Kong C, Zhao X, Gao Y, Zhang Y, Cui W, Zhang C, Jiang J
Format: Article
Language:English
Published: Dove Medical Press 2022-02-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/b16-membrane-coated-vesicles-for-combined-photodynamic-therapy-and-imm-peer-reviewed-fulltext-article-IJN
_version_ 1828427046159646720
author Wang Y
Zhao Z
Liu C
Hao M
Kong C
Zhao X
Gao Y
Zhang Y
Cui W
Zhang C
Jiang J
author_facet Wang Y
Zhao Z
Liu C
Hao M
Kong C
Zhao X
Gao Y
Zhang Y
Cui W
Zhang C
Jiang J
author_sort Wang Y
collection DOAJ
description Yuqian Wang,1,* Zhilong Zhao,2,* Chenlu Liu,3 Miao Hao,1 Chenfei Kong,1 Xiaoming Zhao,1 Yiyao Gao,1 Yucheng Zhang,1 Wanxing Cui,4 Congxiao Zhang,2 Jinlan Jiang1 1Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, 130031, People’s Republic of China; 2Department of Stomatology, The First Hospital of Jilin University, Changchun, 130031, People’s Republic of China; 3Biobank, China-Japan Union Hospital, Jilin University, Changchun, 130031, People’s Republic of China; 4Medstar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC, 20007, USA*These authors contributed equally to this workCorrespondence: Congxiao Zhang; Jinlan Jiang, Email zhangcongxiao@jlu.edu.cn; jiangjinlan@jlu.edu.cnIntroduction: Coating of nanomedicine with cell membranes has attracted increasing attention as it can boost biocompatibility and improve the efficiency of treatment. Herein, we prepared innovative tumor cell-membrane-coated vesicles based on photodynamic therapy (PDT) drug indocyanine green (ICG) and explore the effect on melanoma in vitro and in vivo.Methods: ICG was coated with B16 cell membranes (I@BM NVs) by sonication and extrusion, and the morphological characteristics of I@BM NVs were evaluated by transmission electron microscopy (TEM) and NP-tracking analysis. Homologous cellular uptake was evaluated by flow cytometry (FCM) after staining by DiD dye. Cellular cytotoxicity was evaluated by cell counting kit-8 assay and the anti-tumor effect in vitro was assessed by FCM and western blotting. The anti-tumor effect in vivo was evaluated in a B16 xenograft model in mice. The tumor micro-environment was investigated by FCM and real-time PCR.Results: The vesicles are stable and uniform in nature, and show strong homologous targeting in vivo and in vitro. The vesicles can generate reactive oxygen species to induce apoptosis of B16 cells under near-infrared irradiation. Furthermore, the I@BM NVs induce a significant anti-tumor response in vivo, and perform better with respect to both tumor growth inhibition and lifespan extension. Analysis of immunocytes in the tumor microenvironment showed significant reductions in numbers of myeloid-derived suppressor cells and tumor-associated M2 macrophages in mice in the I@BM NVs group. This was accompanied by significant increases in numbers of M1 macrophages and proliferative CD4+/CD8+ T cells. Expression levels of IFN-γ and IL-2 increased in the I@BM NVs group, while expression of TGF-β and IL-10 decreased.Conclusion: The results show that the I@BM NVs are feasible drugs for the treatment of melanoma by inducing cell apoptosis under NIR and shifting the immunosuppressive tumor microenvironment in vivo.Graphical Abstract: Keywords: melanoma, vesicles, tumor microenvironment, photodynamic therapy, immunotherapy
first_indexed 2024-12-10T16:55:41Z
format Article
id doaj.art-86fd52f1d8434a5fb59fc3580d658282
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-10T16:55:41Z
publishDate 2022-02-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-86fd52f1d8434a5fb59fc3580d6582822022-12-22T01:40:45ZengDove Medical PressInternational Journal of Nanomedicine1178-20132022-02-01Volume 1785586873104B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of MelanomaWang YZhao ZLiu CHao MKong CZhao XGao YZhang YCui WZhang CJiang JYuqian Wang,1,* Zhilong Zhao,2,* Chenlu Liu,3 Miao Hao,1 Chenfei Kong,1 Xiaoming Zhao,1 Yiyao Gao,1 Yucheng Zhang,1 Wanxing Cui,4 Congxiao Zhang,2 Jinlan Jiang1 1Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun, 130031, People’s Republic of China; 2Department of Stomatology, The First Hospital of Jilin University, Changchun, 130031, People’s Republic of China; 3Biobank, China-Japan Union Hospital, Jilin University, Changchun, 130031, People’s Republic of China; 4Medstar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC, 20007, USA*These authors contributed equally to this workCorrespondence: Congxiao Zhang; Jinlan Jiang, Email zhangcongxiao@jlu.edu.cn; jiangjinlan@jlu.edu.cnIntroduction: Coating of nanomedicine with cell membranes has attracted increasing attention as it can boost biocompatibility and improve the efficiency of treatment. Herein, we prepared innovative tumor cell-membrane-coated vesicles based on photodynamic therapy (PDT) drug indocyanine green (ICG) and explore the effect on melanoma in vitro and in vivo.Methods: ICG was coated with B16 cell membranes (I@BM NVs) by sonication and extrusion, and the morphological characteristics of I@BM NVs were evaluated by transmission electron microscopy (TEM) and NP-tracking analysis. Homologous cellular uptake was evaluated by flow cytometry (FCM) after staining by DiD dye. Cellular cytotoxicity was evaluated by cell counting kit-8 assay and the anti-tumor effect in vitro was assessed by FCM and western blotting. The anti-tumor effect in vivo was evaluated in a B16 xenograft model in mice. The tumor micro-environment was investigated by FCM and real-time PCR.Results: The vesicles are stable and uniform in nature, and show strong homologous targeting in vivo and in vitro. The vesicles can generate reactive oxygen species to induce apoptosis of B16 cells under near-infrared irradiation. Furthermore, the I@BM NVs induce a significant anti-tumor response in vivo, and perform better with respect to both tumor growth inhibition and lifespan extension. Analysis of immunocytes in the tumor microenvironment showed significant reductions in numbers of myeloid-derived suppressor cells and tumor-associated M2 macrophages in mice in the I@BM NVs group. This was accompanied by significant increases in numbers of M1 macrophages and proliferative CD4+/CD8+ T cells. Expression levels of IFN-γ and IL-2 increased in the I@BM NVs group, while expression of TGF-β and IL-10 decreased.Conclusion: The results show that the I@BM NVs are feasible drugs for the treatment of melanoma by inducing cell apoptosis under NIR and shifting the immunosuppressive tumor microenvironment in vivo.Graphical Abstract: Keywords: melanoma, vesicles, tumor microenvironment, photodynamic therapy, immunotherapyhttps://www.dovepress.com/b16-membrane-coated-vesicles-for-combined-photodynamic-therapy-and-imm-peer-reviewed-fulltext-article-IJNmelanomavesiclestumor microenvironmentphotodynamic therapyimmunotherapy
spellingShingle Wang Y
Zhao Z
Liu C
Hao M
Kong C
Zhao X
Gao Y
Zhang Y
Cui W
Zhang C
Jiang J
B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma
International Journal of Nanomedicine
melanoma
vesicles
tumor microenvironment
photodynamic therapy
immunotherapy
title B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma
title_full B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma
title_fullStr B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma
title_full_unstemmed B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma
title_short B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma
title_sort b16 membrane coated vesicles for combined photodynamic therapy and immunotherapy shift immune microenvironment of melanoma
topic melanoma
vesicles
tumor microenvironment
photodynamic therapy
immunotherapy
url https://www.dovepress.com/b16-membrane-coated-vesicles-for-combined-photodynamic-therapy-and-imm-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT wangy b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT zhaoz b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT liuc b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT haom b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT kongc b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT zhaox b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT gaoy b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT zhangy b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT cuiw b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT zhangc b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma
AT jiangj b16membranecoatedvesiclesforcombinedphotodynamictherapyandimmunotherapyshiftimmunemicroenvironmentofmelanoma